Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

HKG/2877 stock hub

HKG/2877 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

HKG/2877is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

Hong Kong Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

HKG/2877

In the news

Latest news · HKG/2877

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E6.4

P25 11.7P50 18.9P75 41.4

Trailing P/E6.7

P25 10.7P50 17.9P75 38.5

ROE12.2

P25 -14.7P50 2P75 9.4

ROIC61.9

P25 -10.4P50 1.9P75 10.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All HKG/2877 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

239

Groups with data

Currency

CNY

Showing 239 of 239 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Cayman Islands
Country code	HK
Employees	2,822
Employees Change	-398%
Employees Change Percent	-12.36
Enterprise value	HKD -1B
Exchange	Hong Kong Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	KYG2110P1000
Last refreshed	2026-05-10
Market cap	HKD 7B
Price	HKD 9.31
Price currency	HKD
Rev Per Employee	1,236,401.98x
Sector	Healthcare
Sic	2834
Symbol	hkg/2877
Website	https://www.shineway.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	15.03%
EV Earnings	-0.97x
EV/FCF	-0.94x
FCF yield	15.41%
Forward P/E	6.39x
P/B ratio	0.78x
P/E ratio	6.65x
P/S ratio	2.02x
PE Ratio10 Y	7.22x
PE Ratio3 Y	6.71x
PE Ratio5 Y	6.28x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	21.75%
EBITDA Margin	23.59%
FCF margin	31.07%
Gross margin	72.28%
Gross Profit	HKD 2.5B
Gross Profit Growth	-7.62%
Gross Profit Growth Q	-14.84%
Gross Profit Growth3 Y	-10.51%
Gross Profit Growth5 Y	-7.89%
Net Income	HKD 1.1B
Net Income Growth	13.08%
Net Income Growth Q	56.99%
Net Income Growth Quarters	1%
Net Income Growth Years	1%
Net Income Growth3 Y	-4.9%
Net Income Growth5 Y	1.47%
Pretax Margin	40.48%
Profit Margin	30.3%
Profit Per Employee	HKD 374,597
Profitable Years	23
ROA	4.1
Roa5y	5.33
ROCE	8.25
ROE	12.23
Roe5y	11.91
ROIC	61.86
Roic5y	41.02

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	7.52%
Cagr15y	0.35%
Cagr1y	35.03%
Cagr20y	7.07%
Cagr3y	8.8%
Cagr5y	19.59%
Div CAGR10	4.67%
Div CAGR3	8.29%
Div CAGR5	10.29%
EPS Growth	13.29
EPS Growth Q	58.52
EPS Growth Quarters	1
EPS Growth Years	1
EPS Growth3 Y	-4.9
EPS Growth5 Y	1.47
FCF Growth	18.36%
FCF Growth Q	52.49%
FCF Growth3 Y	-1.06%
FCF Growth5 Y	2.34%
OCF Growth	21.69%
OCF Growth Q	51.8%
OCF Growth10 Y	6.26%
OCF Growth3 Y	-0.09%
OCF Growth5 Y	3.6%
Revenue Growth	-17.01x
Revenue Growth Q	-12.34x
Revenue Growth Years	0x
Revenue Growth3 Y	-9.32x
Revenue Growth5 Y	-7.11x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	HKD 0.3
Assets	HKD 12B
Cash	HKD 8.4B
Current Assets	HKD 10.7B
Current Liabilities	HKD 2.9B
Debt	HKD 372.7M
Debt EBITDA	HKD 0.44
Debt Equity	HKD 0.04
Debt FCF	HKD 0.34
Equity	HKD 9B
Interest Coverage	120
Liabilities	HKD 3B
Long Term Assets	HKD 1.3B
Long Term Liabilities	HKD 130.9M
Net Cash	HKD 8.1B
Net Cash By Market Cap	HKD 115
Net Cash Growth	17.7%
Net Debt EBITDA	HKD -9.79
Net Debt Equity	HKD -0.9
Net Debt FCF	HKD -7.43
Tangible Book Value	HKD 8.8B
Tangible Book Value Per Share	HKD 11.61
WACC	8.45

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.71
Inventory Turnover	1.16
Net Working Capital	HKD -493.4M
Quick ratio	3.42
Working Capital	HKD 7.6B
Working Capital Turnover	HKD 0.54

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend Growth	20.2%
Dividend Growth Years	0%
Dividend per share	HKD 0.54
Dividend Years	22
Dividend Yield	5.81%
Ex Div Date	2026-05-04
Last Dividend	HKD 0.49
Payout Frequency	Semi-Annual
Payout Ratio	37.37%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	106.53%
1Y total return	35%
200-day SMA	8.9
3Y total return	28.79%
50-day SMA	9.43
50-day SMA vs 200-day SMA	50over200
5Y total return	144.55%
All Time High	29.3
All Time High Change	-68.23%
All Time High Date	2010-11-03
All Time Low	2.08
All Time Low Change	348.67%
All Time Low Date	2005-08-11
ATR	0.34
Beta	0.83
Beta1y	0.63
Beta2y	0.71
Ch YTD	8.26
High	9.35
High52	10.47
High52 Date	2026-04-20
High52ch	-11.08%
Low	9.04
Low52	6.96
Low52 Date	2025-05-12
Low52ch	33.76%
Ma50ch	-1.26%
Price vs 200-day SMA	4.57%
RSI	42.95
RSI Monthly	56.24
RSI Weekly	51.82
Sharpe ratio	1.2x
Sortino ratio	2.3
Total Return	5.81%
Tr YTD	13.97
Tr15y	5.41%
Tr1m	0.43%
Tr1w	-0.85%
Tr3m	0.63%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	HKD 759M
Operating Income Growth	5.55
Operating Income Growth Q	13.02
Operating Income Growth3 Y	-10.29
Operating Income Growth5 Y	-6.56
Operating margin	21.75

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	207,037,010%
Net Borrowing	-16,455,836
Shares Insiders	72.59%
Shares Institutions	4.34%
Shares Out	755,400,000
Shares Qo Q	0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	HKD 1.1B
Average Volume	1,141,021.05x
Bv Per Share	11.88
CAPEX	HKD -220.2M
Ch10y	9.79
Ch15y	-52.45
Ch1m	-4.61
Ch1w	-0.85
Ch1y	26.5
Ch20y	44.34
Ch3m	-4.41
Ch3y	5.92
Ch5y	65.95
Ch6m	6.28
Change	-2%
Change From Open	-0.11
Close	9.5
Days Gap	-1.89
Depreciation Amortization	66,166,509.8
Dollar Volume	16,601,061.3
Earnings Date	2026-03-27
EBIT	HKD 759M
EBITDA	HKD 823M
EPS	HKD 1.4
F Score	5
FCF	HKD 1.1B
FCF EV Yield	-106.26x
FCF Per Share	HKD 1.44
Financing CF	-417,318,310
Fiscal Year End	December
Founded	2,002
Goodwill	191,108,797.8
Graham Number	19.33756
Graham Upside	107.7
Income Tax	HKD 355.3M
Investing CF	247,079,485
Is Primary Listing	1
Last Earnings Date	2026-03-27
Last Report Date	2025-12-31
Lynch Fair Value	HKD 7
Lynch Upside	-24.84
Ma150	9.07
Ma150ch	2.7%
Ma20	9.8
Ma20ch	-5.01%
Net CF	1,167,219,992
Open	9.32
P FCF Ratio	6.49
P OCF Ratio	5.39
Payment Date	2026-05-19
Position In Range	87.1
Ppne	1,437,757,561.9
Price Date	2026-05-08
Price EBITDA	HKD 8.55
Ptbv Ratio	0.8
Relative Volume	1.56x
Revenue	3,489,126,395x
Tax By Revenue	10.18x
Tax Rate	25.16%
Tr20y	292.35%
Tr6m	11.89%
Volume	1,783,143
Z Score	3.57

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

HKG/2877 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+5.8%

$0.54 annual per share

Payout ratio

+37.4%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+10.3%

0 consecutive years of growth

Total shareholder yield

+5.8%

Next ex-dividend date: 2026-05-04

Performance

HKG/2877 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns HKG/2877?

Insider, institutional, and short-interest positioning.

Institutional ownership

+4.3%

Share of float held by funds and institutions

Insider ownership

+72.6%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

HKG/2877 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

43.0

Neutral momentum band

Price vs 200-day MA

+4.6%

50/200-day relationship not available

Beta (5Y)

0.83

Moves roughly with the market

Sharpe ratio

1.20

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About HKG/2877

Hub-level FAQ points readers to the deeper analysis pages.

What is the current hkg/2877 stock rating?

hkg/2877 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full hkg/2877 analysis?

The full report lives at /stocks/hkg/2877/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for hkg/2877?

The latest report frames hkg/2877 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the hkg/2877 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.